Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript 03:40 Seeking Alpha En
RBA Breaks Two-Year Pause With Hawkish Rate Hike, AUD/USD Poised For Further Gains 03:05 Seeking Alpha En
Cancom SE (CCCMF) Discusses Strategic Growth and Market Position in DACH IT Services Transcript 03:01 Seeking Alpha En
q.beyond AG (QSCGF) Discusses Strategy Update and Progress Toward Profitability and Growth Targets Transcript 03:01 Seeking Alpha En
